TrialThe Journal of clinical endocrinology and metabolism2025

Octreotide Subcutaneous Depot for Acromegaly: A Randomized, Double-blind, Placebo-controlled Phase 3 Trial, ACROINNOVA 1.

Diego Ferone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.